The Prognostic Value of B12/CRP Ratio (BCR) in Patients Diagnosed With Solid Cancer
In conclusion, our study has shown that BCR, which has not been reported in the literature to date, is one of the cheapest and easily accessible inflammation markers that can determine prognosis in cancer patients.
Authors
- Merve Keskinkılıç (ORCID: https://orcid.org/0000-0002-3342-3144)
- Elif Başaran (ORCID: https://orcid.org/0000-0001-8367-0242)
- Tuğba Yavuzşen (ORCID: https://orcid.org/0000-0001-9375-8133)
Institutions
- Izmir University (TR)
- University of Health Science (KH)
- Dokuz Eylül University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/11795549251360891
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00